Market Access How transparent is the VPAG? Leela Barham takes a look at the transparency of the UK’s new pricing and access scheme, the 2024 VPAG, based on public sources.
Sales & Marketing How transparent is the VPAS? The UK’s VPAS – a deal that began on 1st January 2019 and which is due to end on 31st December 2023 – is worth around £7 billion.
News Astellas places $2bn+ bet on AviadoBio dementia gene therapy Astellas has added another gene therapy to its pipeline, taking an option on a clinical-stage candidate for a rare genetic form of dementia from UK biotech AviadoBio for around $50 million.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
